Novartis takes aim at Roche's star MS drug

Swiss drugmaker Novartis on Friday stepped up its challenge to Roche's multiple sclerosis franchise, highlighting study results for its MS hopeful ofatumumab that could compete with its cross-town rival's drug Ocrevus.

from Reuters: Health News https://ift.tt/2ML3o2v